Reconstruction After Abdominoperineal Resection With Robot-assisted Harvest of VRAM Flap
Launched by OSLO UNIVERSITY HOSPITAL · Jan 10, 2023
Trial Information
Current as of November 05, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new way to help patients recover after surgery for rectal or anal cancer. Specifically, it looks at using a robot-assisted technique to reconstruct the pelvic area using a flap of muscle from the abdomen. This method aims to improve healing, reduce complications, and enhance sexual health after surgery.
To participate, patients should be between 65 and 74 years old and have been diagnosed with rectal or anal cancer. They must be scheduled for a specific type of surgery called abdominoperineal resection and be suitable for the robot-assisted approach. Participants will be monitored for their recovery, including how well their wounds heal and their overall strength in the abdominal area, as well as their sexual health before and after the procedure. This trial is currently recruiting, and it offers a chance to contribute to important research that may improve future surgical outcomes for similar patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • patients with rectal or anal cancer
- • scheduled for robot-assisted abdominoperineal resection
- • reconstruction of pelvic floor and/or vagina with rectus abdominis muscle flap
- Exclusion Criteria:
- • patients not eligible for robot-assisted procedure
- • rectus abdominis muscle not available for harvest
- • the expected wound defect is not suitable for reconstruction with rectus abdominis muscle flap
About Oslo University Hospital
Oslo University Hospital is a leading academic medical center in Norway, renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a prominent sponsor of clinical studies, the hospital integrates cutting-edge scientific inquiry with patient care, fostering an environment that promotes the development of new therapies and treatment strategies. With a multidisciplinary approach, Oslo University Hospital collaborates with various stakeholders, including researchers, healthcare professionals, and industry partners, to enhance clinical outcomes and contribute to the global medical community. Its dedication to ethical standards and patient safety ensures that all trials are conducted with the highest level of integrity and respect for participant welfare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Oslo, Norway
Patients applied
Trial Officials
Lars Frich, MD, PhD
Principal Investigator
Oslo University Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials